CROSSPOINT FINANCIAL, LLC - Q3 2023 holdings

$9.46 Million is the total value of CROSSPOINT FINANCIAL, LLC's 9 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 10.0% .

 Value Shares↓ Weighting
BRKB  BERKSHIRE HATHAWAY INC DELcl b new$3,014,335
+2.7%
8,6050.0%31.86%
+6.7%
FIVG SellETF SER SOLUTIONSdefiance next$1,635,501
-29.2%
52,327
-23.7%
17.29%
-26.4%
OIH BuyVANECK ETF TRUSToil services etf$1,617,897
+22.6%
4,689
+2.2%
17.10%
+27.4%
IHAK BuyISHARES TRcybersecurity$1,455,288
+13.1%
37,790
+11.0%
15.38%
+17.5%
 FIRST TR EXCHNG TRADED FD VIft cboe vest us$763,536
-1.0%
23,0500.0%8.07%
+2.9%
IAU SellISHARES GOLD TRishares new$608,549
-16.6%
17,392
-13.2%
6.43%
-13.3%
FB  META PLATFORMS INCcl a$325,729
+4.6%
1,0850.0%3.44%
+8.7%
ALLO  ALLOGENE THERAPEUTICS INC$38,040
-36.2%
12,0000.0%0.40%
-33.8%
 MICROVAST HOLDINGS INC*w exp 04/01/202$1,950
-4.9%
10,0000.0%0.02%0.0%
TERN ExitTERNS PHARMACEUTICALS INC$0-12,054
-100.0%
-1.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL4Q3 202331.9%
ETF SER SOLUTIONS4Q3 202324.5%
VANECK ETF TRUST4Q3 202317.1%
ISHARES TR4Q3 202315.4%
FIRST TR EXCHNG TRADED FD VI4Q3 20238.1%
ISHARES GOLD TR4Q3 20238.1%
MICROVAST HOLDINGS INC4Q3 20230.0%
META PLATFORMS INC3Q3 20233.4%
TERNS PHARMACEUTICALS INC3Q2 20231.7%
ALLOGENE THERAPEUTICS INC2Q3 20230.6%

View CROSSPOINT FINANCIAL, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-24
13F-HR2024-02-07
13F-HR2023-11-14
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-08

View CROSSPOINT FINANCIAL, LLC's complete filings history.

Export CROSSPOINT FINANCIAL, LLC's holdings